Gastroenterology and Hepatology

Episodes 1-16 of 45

Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
Clinician's Roundtable
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
- Aasma Shaukat, MD, MPH
Postcolonoscopy Colorectal Cancer: Optimizing Quality to Reduce Risk
Postcolonoscopy Colorectal Cancer: Optimizing Quality to Reduce Risk
Clinician's Roundtable
Postcolonoscopy Colorectal Cancer: Optimizing Quality to Reduce Risk
- Aasma Shaukat, MD, MPH
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Project Oncology®
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
- Ryan Quigley
- Hallie Blevins, PhD.
- Marlene Mimi Maeusli, PhD.
Improving Colorectal Cancer Screening Adherence: Advantages of FIT
Improving Colorectal Cancer Screening Adherence: Advantages of FIT
Clinician's Roundtable
Improving Colorectal Cancer Screening Adherence: Advantages of FIT
- Theodore Levin, MD
Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Clinician's Roundtable
Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
- Ashley Baker, MSN, PMHNP
- Heather Allen, PhD
- Ran Li, PhD
Initiating Colorectal Cancer Screening Earlier: A Look at the Evidence
Initiating Colorectal Cancer Screening Earlier: A Look at the Evidence
Clinician's Roundtable
Initiating Colorectal Cancer Screening Earlier: A Look at the Evidence
- Theodore Levin, MD
Boosting Colorectal Cancer Re-Screening: The Role of Spanish Language Navigation
Boosting Colorectal Cancer Re-Screening: The Role of Spanish Language Navigation
Clinician's Roundtable
Boosting Colorectal Cancer Re-Screening: The Role of Spanish Language Navigation
- Ryan Quigley
- Mallik Greene, PhD
Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Clinician's Roundtable
Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
- Pedro Nascimento de Lima, PhD
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Clinician's Roundtable
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
- Charles Turck, PharmD, BCPS, BCCCP
- Gloria Coronado, PhD
Treating Gastrointestinal Neuroendocrine Carcinoma: Beyond Lung-Based Approaches
Treating Gastrointestinal Neuroendocrine Carcinoma: Beyond Lung-Based Approaches
Project Oncology®
Treating Gastrointestinal Neuroendocrine Carcinoma: Beyond Lung-Based Approaches
- Namrata Vijayvergia, MD
The Evolving Treatment Landscape for Extrapulmonary Neuroendocrine Carcinomas
The Evolving Treatment Landscape for Extrapulmonary Neuroendocrine Carcinomas
Project Oncology®
The Evolving Treatment Landscape for Extrapulmonary Neuroendocrine Carcinomas
- Namrata Vijayvergia, MD
DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
Project Oncology®
DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
Assessing Efficacy and Cost of Blood-Based Tests for Colorectal Cancer
Assessing Efficacy and Cost of Blood-Based Tests for Colorectal Cancer
Clinician's Roundtable
Assessing Efficacy and Cost of Blood-Based Tests for Colorectal Cancer
- Charles Turck, PharmD, BCPS, BCCCP
- Samuel Muench, MD
Liquid Biopsy for Colorectal Cancer Screening: Benefits and Barriers
Liquid Biopsy for Colorectal Cancer Screening: Benefits and Barriers
Clinician's Roundtable
Liquid Biopsy for Colorectal Cancer Screening: Benefits and Barriers
- Charles Turck, PharmD, BCPS, BCCCP
- Brennan Spiegel, MD, MSHS
Studying Carboplatin-Paclitaxel + Retifanlimab for Squamous Cell Carcinoma of the Anal Canal
Studying Carboplatin-Paclitaxel + Retifanlimab for Squamous Cell Carcinoma of the Anal Canal
Project Oncology®
Studying Carboplatin-Paclitaxel + Retifanlimab for Squamous Cell Carcinoma of the Anal Canal
- Charles Turck, PharmD, BCPS, BCCCP
- Richard Kim, MD
Uncovering Unmet Needs in Squamous Cell Carcinoma of the Anal Canal Care
Uncovering Unmet Needs in Squamous Cell Carcinoma of the Anal Canal Care
Project Oncology®
Uncovering Unmet Needs in Squamous Cell Carcinoma of the Anal Canal Care
- Richard Kim, MD